Managing sleep problems, eating difficulties and and procedural anxiety in children with cancer

Linvoseltamab can be a potentially effective treatment option for patients with relapsed/refractory multiple myeloma

Positive data for the use of radioligand therapy in first-line neuroendocrine cancers

Defining geriatric oncology

Multiple myeloma In Rwanda: The need for further research

Addressing the rise of multiple myeloma in Rwanda

Revolving door between the regulators and industry

Durable responses in aRCC, how do we optimise treatment?

Perspectives on advance care planning for advanced cancer in the Philippines

Bladder cancer updates from the first half of 2024

The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC

Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC